Akebia Therapeutics, Inc. (AKBA)
0.9972
-0.01
(-1.27%)
USD |
NASDAQ |
May 19, 09:38
Akebia Therapeutics Total Liabilities (Quarterly) : 335.14M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 2.959B |
| MannKind Corp. | 803.60M |
| United Therapeutics Corp. | 813.10M |
| Ardelyx, Inc. | 355.88M |
| Rhythm Pharmaceuticals, Inc. | 319.41M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 362.52M |
| Shareholders Equity (Quarterly) | 27.38M |
| Debt to Equity Ratio | 7.961 |
| Current Ratio | 1.400 |
| Net Debt Paydown Yield | -1.25% |